The Recombinant Erythropoietin Market set for robust growth driven by increasing use of biosimilars by 2031 The recombinant erythropoietin market deals with use of biosimilar medicines for treatment of anemia and blood related disorders. Recombinant erythropoietin is a man-made form of endogenous protein hormone erythropoietin that stimulates bone marrow to produce red blood cells.... https://www.coherentmarketinsights.com/market-insight/recombinant-erythropoietin-market-5960#:~:text=The%20global%20recombinant%20erythropoietin%20market,3.1%25%20from%202023%20to%202030.